04:21 PM EDT, 06/05/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on June 03, 2024, sold 7,500 shares in Revolution Medicines ( RVMD ) for $299,942. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 848,774 shares of the company, with 322,322 shares held directly and 526,452 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000285/xslF345X03/form4.xml

Price: 39.90, Change: -0.78, Percent Change: -1.92